Latest Cancer News
PET/CT Improves Detection of Inoperable Lung Cancer
(07/02/2009)
Preoperative lung cancer staging with combined PET/CT imaging allows some patients to avoid futile surgery. These results were published in the New England Journal of Medicine.Amgen Helps Reduce Out-of-pocket Costs for Neulasta®
(07/02/2009)
Amgen’s Neulasta FIRST STEP™ Program provides assistance to eligible, low-income, commercially-insured chemotherapy patients who need help with their co-insurance or co-payment requirement for Neulasta® (pegfilgrastim).Sutent® Fails to Show Benefit in Metastatic Colorectal Cancer
(07/01/2009)
The combination of the targeted therapy Sutent® (sunitinib) and FOLFIRI chemotherapy did not result in better progression-free survival than FOLFIRI alone among patients with metastatic colorectal cancer, prompting a Phase III clinical trial of the combination treatment to be stopped early. This information was made available in a press release from Pfizer. |
What's New
Grant Awarded for Community Education Regarding Clinical Trials
Connecticut Oncology and Hematology is proud to announce that the practice is the recipient of a grant from the Connecticut Clinical Trials Network.
On August 3rd, 2008 The fifth annual Tour of the Litchfield Hills was attended by more than 1100 participants that raised about $100,000 to benefit cancer patients of the Northwest Connecticut area.
On June 26th weekend in Winsted Ct., and August 16th weekend in Caanan Ct.,Connecticut Oncology-Hematology participated in the two area RELAY FOR LIFE events.
Read More »
Research at Connecticut Oncology
PACCT-1
(Program for the Assessment of Clinical Cancer Tests) - ER-Positive and/or PR-Positive Breast Cancer Axillary Node-Negative Candidate for Adjuvant Cytotoxic Therapy in Addition to Hormonal Therapy.
E5597
Phase III Chemopreventive Trial of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer
Read More »
|
Locations
New Milford Location
New Milford Hospital
Cancer Center
21 Elm St.
New Milford, CT 06776
860-350-7283
|